“Diagnostics startup Blueprint Genetics puts expansion to the test” / Tekes

Published on November 15, 2015

“After establishing an office in the USA, business is set to grow tenfold for this genetic testing company in the near future.

The road to success for startups is one that is typically paved with various twists and turns. Whilst a company may start out with an original idea, in time circumstances often dictate a sharp lurch into unexpected territory. Sometimes further tweaks are still needed to the business model before a successful approach is found. Not so for diagnostics company Blueprint Genetics…”

Read more in the article by James O’Sullivan, published by Tekes

https://www.tekes.fi/en/tekes/results-and-impact/cases1/2015/diagnostics-startup-blueprint-genetics-puts-expansion-to-the-test/

Last modified: 11.15.2015

News

Blueprint Genetics expands capabilities in the detection and confirmation of difficult-to-sequence regions

Published on October 17, 2018

The latest advancement in Blueprint Genetics’ production environment involves customized sequencing solutions for difficult-to-sequence genes, designed to maximize detection of clinically relevant variants. Currently, the most extensive developments are in genes SMN1/SMN2, PKD1 and RPGR (ORF15), associated with spinal muscular atrophy, autosomal dominant polycystic kidney disease and X-linked retinitis pigmentosa,…

Read more

Subscribe to our newsletter